UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
Back to Urology at UCLA home It Begins With U

Urology at UCLA

Print
Email
Share
Search Our Physician Directory

Donate Today

Physicians and Research Faculty

Chair

Mark S. Litwin, MD, MPH
Mark S. Litwin, MD, MPH
Chair, Department of Urology. Professor of Urology and Public Health. He trained at Harvard and specializes in testicular, bladder, prostate and kidney cancer. Dr. Litwin’s research focuses on improving quality of care and quality of life in urologic oncology. He leads Urologic Diseases in America (www.udaonline.net), the NIH’s largest effort at documenting the burden of urologic diseases on the American people. He also created and directs IMPACT, a state-funded program that provides free medical care statewide for low-income, uninsured men with prostate cancer (www.california-impact.org).
 

Faculty Members

William Aronson, MD
William Aronson, MD
Chief of Urology at Olive View UCLA Medical Center and Chief of Urologic Oncology, Veterans Administration West Los Angeles. His clinical specialties are Prostate Cancer and General Urology. His clinical and laboratory research focuses on treatment of advanced prostate cancer and diet and lifestyle factors for chemoprevention and treatment.
 
Z. Chad Baxter, MD
Z. Chad Baxter, MD
Assistant Clinical Professor of Urology. Dr. Baxter completed his M.D. at Loma Linda University School of Medicine, urology residency at Penn State University, and fellowship training in Pelvic Medicine and Reconstructive Surgery at UCLA. Previously the Director of Pelvic Health and Reconstructive Surgery at North Shore – Long Island Jewish Health System in New York, Dr. Baxter’s clinical interests are in male and female voiding dysfunction, urinary incontinence, general adult urology, and genitourinary and pelvic floor reconstruction.
 
Arie Belldegrun, MD, FACS
Arie Belldegrun, MD, FACS
Director of the Institute of Urologic Oncology (www.iuo.ucla.edu); Professor of Urology; Chief, Division of Urologic Oncology; Founder and Surgical Director, UCLA Kidney Cancer Program (www.kidneycancer.ucla.edu). Dr. Belldegrun also holds the Roy and Carol Doumani Chair in Urologic Oncology and serves as the Director of the Urologic Oncology Fellowship Program at UCLA. His surgical expertise encompasses all aspects of urologic oncology, including kidney cancer, prostate cancer, bladder cancer and testicular cancer. He has authored over 400 peer-reviewed publications, books, and book chapters in the area of localized and advanced kidney and prostate cancer. Dr. Belldegrun is a world-renown expert in complicated kidney cancer surgeries, and has unique expertise in a variety of surgical approaches to small kidney tumors including open, laparoscopic, and robotic partial nephrectomy and cryotherapy. He is also a recognized expert in minimally invasive and focal prostate cancer therapy, specifically cryo-surgical prostate cancer ablation, and has published extensively his UCLA experience with cryotherapy. Dr. Belldegrun's research lab at UCLA focuses on the development of personalized cancer immunotherapy and targeted cancer vaccines for the treatment of kidney cancer.
 
Carol Bennett, MD
Carol Bennett, MD
Affiliated Programs: General Adult Urology
Chief of Urology, West Los Angeles VA Healthcare Center. Her research interests are focused on the treatment of neurogenic bladder disorder, sexual dysfunction, and infertility. Currently a board member of the American Foundation of Urologic Diseases, and the Pfizer/AUA Visiting Professorships in Urology. Dr. Bennett is also a Professor at David Geffen School of Medicine, UCLA.
 
Jonathan Bergman, MD
Jonathan Bergman, MD
Affiliated Programs: Male Urology, Urologic Oncology
Assistant Professor of Urology and Family Medicine, Dr. Bergman attended Yale University, where he graduated Phi Beta Kappa and summa cum laude with a degree in Molecular, Cellular and Developmental Biology. He attended UCLA Medical School and graduated as an Alpha Omega Alpha member in 2005. He completed UCLA Urology residency in 2011 and completed a Robert Wood Johnson Clinical Scholarship. His research goals include improving value in end of life care, integrating care for individuals with advanced cancer, residency and medical student education, and safety net delivery systems.
 
Jeremy M. Blumberg, MD
Jeremy M. Blumberg, MD
Dr. Jeremy Blumberg is an Assistant Professor of Urology. He received his B.S. in the History of Science and Medicine from The University of Wisconsin, Madison, and his M.D. from George Washington University in Washington, DC. Dr. Blumberg completed his urology residency at Kaiser Permanente in Los Angeles; he then completed a two-year fellowship in kidney transplantation at UCLA. His clinical interests include kidney transplantation, genitourinary trauma, urologic oncology, and resident education. Dr. Blumberg also has a strong interest in the medical humanities, specifically in improving the quality of patient and physician's lives through writing, art and music.
 
Karim Chamie, MD, MSHS
Karim Chamie, MD, MSHS
Assistant Professor-in-Residence of Urology. He attended Medical School at USC and completed Urological training at UC Davis. Dr. Chamie then completed a SUO certified fellowship in Urologic Oncology at UCLA. His primary research interests are health services research and clinical trials in bladder cancer. His clinical interests include all areas of urologic oncology, with a particular emphasis on bladder cancer and robotic surgery.
 
Arnold I. Chin, MD, PhD
Arnold I. Chin, MD, PhD
Assistant Professor of Urology. Dr. Chin completed his M.D., Ph.D. and Urology residency training at UCLA. His clinical expertise includes urologic oncology and renal transplantation, with a focus on bladder cancer. He performs open, laparoscopic, and robotic-assisted surgeries for bladder, kidney, and prostate cancer patients. Dr. Chin's laboratory in the Broad Stem Cell Research Institute studies the tumor microenvironment in prostate and bladder cancer in efforts to develop novel immune and stem cell-based therapies against cancer.
 
Bernard M. Churchill, MD
Bernard M. Churchill, MD
Affiliated Programs: Pediatric Urology Program
Judith and Robert Winston Chair in Pediatric Urology and founding director of Clark Morrison Children's Urological Center at UCLA. Previously, Chief of Urology at the Hospital for Sick Children in Toronto, Canada. Dr. Churchill is the 25th Recipient of the Urology Medal granted by the American Academy of Pediatrics in recognition of outstanding career accomplishments.
 
Jean B. DeKernion, MD
Jean B. DeKernion, MD
Professor Emeritus of Urology. Residency, Case Western Reserve in Cleveland, fellowship, National Cancer Institute. Certified by the American Board of Surgery and American Board of Urology. World leader in Urologic Oncology, co-authored the first textbook on the subject. Founder, Society of Urologic Oncology, member of the American Board of Urology, Chair, Department of Defense prostate cancer Research program. Kidney, bladder and prostate cancer are the areas in which he has made the most significant contributions.
 
Alexandra Drakaki, MD
Alexandra Drakaki, MD
Affiliated Programs: Urologic Oncology
Clinical Instructor in Urology and Hematology/Oncology. Dr. Drakaki completed her residency in Internal Medicine at Tufts University, and her Hematology/Oncology fellowship in Beth Israel Deaconess Medical Center at Harvard Medical School. She specializes in genitourinary malignancies, primarily bladder, testicular and prostate cancer. Dr. Drakaki's research focuses on identifying the therapeutic potential of novel genes named micro-RNAs that are involved in bladder carcinogenesis.
 
Richard M. Ehrlich, MD
Richard M. Ehrlich, MD
Professor Emeritus of Urology. Dr. Ehrlich completed his medical degree from Cornell University. He has served as president of both the Society for Pediatric Urology and the American Academy of Pediatrics Urology Section as well as other leadership positions in the David Geffen School of Medicine, UCLA. His clinical interests include general urology and pediatric urology.
 
Stanley Frencher Jr., MD, MPH
Stanley Frencher Jr., MD, MPH
Affiliated Programs: General Adult Urology
Assistant Professor and Director of Urology at Martin Luther King, Jr. Community Hospital (MLKCH). Dr. Frencher received his MD from Albert Einstein College of Medicine and concurrently his MPH as a Macys Scholar from Columbia University's Mailman School for Public Health, his residency in General Surgery and Urology from Yale-New Haven Hospital and completed a Robert Wood Johnson Foundation Clinical Scholars Program at the University of California Los Angeles. He will focus on men's health, outcomes and community-partnered research, as well as leading the urology effort at MLKCH.
 
Isla Garraway, MD
Isla Garraway, MD
Associate Professor of Urology at UCLA, Attending Urologist, Greater Los Angeles-VA Medical Center. Dr. Garraway’s primary clinical and research focus is on prostate cancer. She is a member of the Jonsson Comprehensive Cancer Center and heads a laboratory investigating prostate development and carcinogenesis.
 
Hans Gritsch, MD
Hans Gritsch, MD
Affiliated Programs: Kidney Transplant Program
Surgical Director, Kidney Transplantation Program at UCLA. The program performs both deceased and living donor transplants. His basic research interest is in the development of new ways of monitoring the immune system after transplant to reduce the risk of rejection and the complications of the immune suppressing drugs.
 
Stuart Holden, MD
Stuart Holden, MD
Affiliated Programs: Prostate Cancer
Health Sciences Clinical Professor of Urology and Associate Director, UCLA Institute of Urologic Oncology. Dr. Holden is recognized as an expert in prostate cancer research throughout the medical community. His dedication to patient care led to him being named medical director of the Prostate Cancer Foundation. Prior to joining UCLA, Holden was the director of the Louis Warschaw Prostate Cancer Center at Cedars-Sinai Medical Center and the first holder of the Warschaw, Robertson, Law Families Chair in Prostate Cancer.
 
Jim C. Hu, MD, MPH
Jim C. Hu, MD, MPH
Director and Henry Singleton Chair in Robotic and Minimally Invasive Surgery, Co-Director of the UCLA Center for Advanced Surgical and Interventional Technology and Director of the Urology Procedures Unit at UCLA. Dr. Hu is internationally renowned as a surgical innovator and for his comparative effectiveness research on robotic-assisted surgery to treat prostate, kidney and bladder cancer. He has performed over 2000 robotic-assisted procedures and was previously the Director of Robotic Surgery at Brigham and Women's Hospital-Harvard Medical School and Director of Prostate Cancer at the Dana Farber-Harvard Cancer Center before his recruitment to UCLA in 2012.
 
Jiaoti Huang, MD, PhD
Jiaoti Huang, MD, PhD
Affiliated Programs: Anatomic Pathology
Dr. Jiaoti Huang received his M.D. from Anhui Medical University, and his Ph.D. from NYU School of Medicine. Dr. Huang did his residency at NYU and fellowship at Memorial Sloan-Kettering Cancer Center. Dr. Huang is Professor of Pathology and Urology, Director of Urologic Pathology, Co-Director of the Pathway Pathology Laboratory in UCLA’s Institute of Molecular Medicine and a member of the Broad Center of Regenerative Medicine and Stem Cell Research. His clinical interest is in the diagnosis of tumors of the prostate, bladder, kidney and testis. His research interest is in prostate cancer.
 
Gregory S. Jack, MD, FRACS
Gregory S. Jack, MD, FRACS
Assistant Professor, Director of UCLA Kidney Stone Center. Dr. Jack is a fellowship trained specialist in kidney stones and laparoscopic surgery. He received his BA from Cornell, MD from Vanderbilt, Urology residency at UCLA, and Fellowship at Austin Health, Melbourne, Australia. His research focuses on biomedical engineering, minimally invasive surgery, and kidney stones. He has been awarded numerous honors by the American Urological Association.
 
Fairooz Kabbinavar, MD, FACP
Fairooz Kabbinavar, MD, FACP
Affiliated Programs: Kidney Cancer, Urologic Oncology
Professor of Medicine and Urologic Oncology, Medical Director of UCLA Kidney Cancer Program and Henry Alvin and Carrie L. Meinhardt endowed chair in Kidney cancer research. Dr. Fairooz Kabbinavar received his B.Sc., M.B.B.S. and M.D. degrees from Nagpur University in India. In UCLA's Division of Hematology/Oncology, he did his postdoctoral research fellowship and a clinical Hematology-Oncology fellowship, with his internship and residency at Beth Israel Hospital at Harvard University in Boston. Dr.Kabbinavar's research interests are in anti-angiogenic and novel targeted therapeutics. His work was responsible for the FDA approval of Bevacizumab.
 
Ja-Hong Kim, MD
Ja-Hong Kim, MD
Assistant Professor, Division of Pelvic Medicine and Reconstructive Surgery, Department of Urology. Dr. Kim completed her MD at Baylor College of Medicine, Urology residency training at Cleveland Clinic, and Pelvic Medicine and Reconstructive Surgery fellowship at UCLA. Her clinical areas of interest include voiding dysfunction, vaginal prolapse, and genitourinary reconstruction. She performs pelvic floor reconstruction, laparoscopic, and robotically-assisted surgery.
 
Christopher King, MD, PhD
Christopher King, MD, PhD
Affiliated Programs: Radiation Oncology
Dr. Christopher King PhD-MD is Associate Professor of Radiation Oncology & Urology at UCLA. He obtained his PhD in Astrophysics from Yale and his MD from Boston University. He completed his residency in Radiation Oncology at Yale and a research fellowship at Tufts. He was faculty at Stanford for nine years before joining UCLA in 2009. His areas of clinical and research interests are GU cancers (prostate, bladder, testicular and kidney) and primarily prostate cancer. His expertise ranges from the technical aspects of radiotherapy, the radiobiology of prostate cancer, the pathological and clinical factors associated with the optimal selection of treatment in both the primary and post-operative setting, and the imaging of prostate cancer (PET, CT, MRI).
 
David A. Leff, MD
David A. Leff, MD
Dr. Leff has been in private practice for over 35 years and is currently an Assistant Clinical Professor of Urology at the David Geffen School of Medicine at UCLA. Dr. Leff has a clinical interest in the treatment of diseases of the prostate, urinary stone disease, erectile dystunction and general urology.
 
Steve Lerman, MD, FAAP
Steve Lerman, MD, FAAP
Affiliated Programs: Pediatric Urology Program
Dr. Lerman helped to advance the use of laparoscopic surgery in children with great success. He participates in clinical trials investigating new treatments for urological conditions in children. He has advanced the use of minimally invasive techniques in the treatment of vesicoureteral reflux, a common reason for pediatric urologic referral.
 
Leonard S. Marks, MD
Leonard S. Marks, MD
Professor of Urology, completed training at UCLA in 1978. Received an American Foundation for Urologic Diseases scholarship award and a prostate cancer Foundation research award. His current research interests involve prostate markers, imaging, and minimally-invasive treatments.
 
James A. Orecklin, MD, MPH
James A. Orecklin, MD, MPH
Clinical Professor of Urology, Dr. Orecklin received his M.D. from the University of Michigan in 1965. He completed his Urology residency at UCLA in 1973 and has been on the clinical faculty since 1973. In 1997 he received a Masters in Public Health in Healthcare Policy and Administration, at UCLA. He is the Medical Director of the IMPACT program.
 
Allan Pantuck, MD, MS, FACS
Allan Pantuck, MD, MS, FACS
Professor of Urology, Dr. Pantuck specializes in urologic cancers and has a long standing interest in kidney, prostate, bladder cancers, developing new treatment strategies through basic and clinical research and in the study of nutritional approaches to their prevention and treatment.
 
Jacob Rajfer, MD
Jacob Rajfer, MD
Professor of Urology at UCLA and Chief of Urology, Harbor-UCLA Medical Center. Head of the male infertility and male sexual dysfunction clinic, Urology. Dr. Rajfer was one of the discoverers of the mechanism by which a man’s erection occurs which led to the discovery of drugs like Viagra. Dr. Rajfer also treats men with benign and malignant prostate disorders.
 
Steven Raman, MD
Steven Raman, MD
Dr. Steven Raman is a Professor of Radiology and Urology and is an expert in Urological Radiology, having published over 75 papers, 100 abstracts and several book chapters in this field. He has been the founding member of the UCLA Prostate Imaging Group, whose members include physicians and scientists dedicated to advancing the field of prostate imaging. Dr. Raman believes that MR imaging the best non-invasive solution for finding the most aggressive prostate cancer.
 
Shlomo Raz, MD
Shlomo Raz, MD
Oversees Division of Female Urology, Reconstructive Surgery, Urodynamics. He is a leader in developing new treatments for female urology conditions and has pioneered innovations that are standards of care worldwide for vaginal, uterine prolapse, urinary incontinence, pelvic floor disorders, voiding dysfunction, and surgical reconstruction after cancer.
 
Robert E. Reiter, MD
Robert E. Reiter, MD
Professor, Urology, Molecular Biology, Director of the Prostate Cancer Program, Director of Urologic Research, Co-Director of the Genitourinary Oncology Program in UCLA's Jonsson Cancer Center. Attended Stanford Medical School, completed urologic training at Stanford and Baylor College of Medicine, completed additional fellowship training in urological cancer at the National Cancer Institute. His clinical interests include all areas of urologic oncology, with an emphasis on prostate cancer. He specializes in robotically-assisted prostatectomy and cystectomy, as well as open surgery, with robotic experience dating back to 2004, for bladder, prostate, and renal malignancies. Dr. Reiter is involved in all aspects of urologic oncology, with an emphasis on prostate cancer, and brings extensive experience in robotic surgery and the applications of translational research and the latest in MRI and molecular imaging to the management of men with this disease.
 
Matthew Rettig, MD
Matthew Rettig, MD
Matthew Rettig, M.D., is a Professor in the Department of Medicine, Division of Hematology-Oncology, and the Department of Urology, and is the Medical Director of the Prostate Cancer Program of the Institute of Urologic Oncology at UCLA. Dr. Rettig received his medical degree from Duke University and internal medicine residency at the University of Washington, before going on to a hematology-oncology fellowship at UCLA. Dr. Rettig’s focus is on management of genitourinary malignancies, with a clinical emphasis on advanced prostate cancer and research emphasis on identifying biochemical targets for therapeutic translation in castration-resistant prostate cancer and clear cell renal cell carcinoma. Dr. Rettig also serves as the director of the clinical trials program in prostate cancer at UCLA.
 
John T. Rosenthal, MD
John T. Rosenthal, MD
A specialist in renal transplantation, Dr. Rosenthal received NIH funding for participation in the first NIH sponsored clinical trials in transplantation. Dr. Rosenthal now serves as the Chief Medical Officer of the UCLA Hospital System and is Associate Vice Chancellor in the David Geffen School of Medicine at UCLA.
 
Jonathan Said, MD
Jonathan Said, MD
Dr. Jonathan Said is Professor of Pathology and Urology at the David Geffen School of Medicine and Chief of Anatmic and Surgical Pathology at UCLA Medical Center. He is an expert in the pathology diagnosis of urologic diseases, and has published extensively on neoplastic diseases of the kidney and prostate.
 
Christopher Saigal, MD, MPH
Christopher Saigal, MD, MPH
Professor and Vice Chair, Urology. Clinical practice, UCLA Westwood Campus. He is also on the staff of the West Los Angeles Veterans Affairs Medical Center. Dr. Saigal has had a longstanding clinical interest in urologic cancers and the surgical treatment of benign prostatic hyperplasia. His research is focused on patient-centered decision support and quality of care for urologic conditions.
 
Jennifer Singer, MD
Jennifer Singer, MD
Affiliated Programs: Pediatric Urology Program
Clinical interests include adult and pediatric renal transplantation and end-stage renal disease. Special interests and training in congenital urologic anomalies. Dr. Jennifer Sandra Singer's research interests include the use of transplant immunosuppression and the molecular aspects of chronic allograft rejection. Special interest in urinary tract dysfunction in pediatric patients with end-stage renal disease.
 
Robert B. Smith, MD
Robert B. Smith, MD
Professor, Urology. Faculty member, completed UCLA residency, 1969. Assistant Professor of Urology, Chief of the Renal Transplant service. Associated Professor of Urology / Professor of Urology. Served in the Air Force, Lieutenant Colonel, Chief of Urology, Lackland Air Force Base. Vice-Chairman, Urology, Chief of Staff, UCLA Medical Center. Director, Urology residency training. His clinical interests are in the treatment of urologic malignancies, and in reconstructive urologic cases.
 
Christopher Tarnay, MD
Christopher Tarnay, MD
Affiliated Programs: Obstetrics and Gynecology
Associate Professor in the Department of Obstetrics & Gynecology and the Department of Urology. Chief of the Division of Female Pelvic Medicine & Reconstructive Surgery in Obstetrics & Gynecology. As a urogynecologist, he is an authority in urinary incontinence and vaginal reparative surgery. He specializes in Robotic Surgery for the treatment of pelvic organ prolapse and is Co-Chair of the Robotic Surgery program at UCLA. Each year, Dr. Tarnay travels to Uganda, Africa to help lead a team of doctors and nurses, providing expertise and education to local physicians in an effort to reduce maternal deaths and treat one of the most debilitating consequences to childbirth, urinary fistulae.
 
Jeffrey Veale, MD
Jeffrey Veale, MD
Associate Professor and Director of the UCLA Kidney Exchange Transplantation Program, Dr. Veale's National Institutes of Health (NIH) funded research focuses on altruistic donors and bridge donors in an effort to ultimately expand the donor pool. The UCLA exchange program under Dr. Veale's direction has performed more chain transplants than any other single center in the world, and pioneered the first transcontinental chain transplant in the United States.
 
Nazy Zomorodian, RNC, MSN, CUNP, CCRC
Nazy Zomorodian, RNC, MSN, CUNP, CCRC
Ms. Zomorodian is the Director of the Genitourinary Clinical Trials and a Nurse Practitioner for the Department of Urology. She received her BS and Masters of Science in Nursing from the Hahnermann University in Philadelphia and is working on her PhD in Research Nursing at UCLA. Ms. Zomorodian is also certified by the Association of Clinical Research Professional as a Clinical Research Coordinator. She has extensive experience in managing and conducting cancer research and she also works closely with UCLA's urologic and medical oncology principal investigators in basic research. Ms. Zomorodian regularly instructs physicians, fellows, residents and nurses on all aspects of clinical trials for kidney, prostate and bladder cancers.
 

Research Faculty

Nestor Gonzalez-Cadavid, PhD
Nestor Gonzalez-Cadavid, PhD
Adjunct Professor, Urology, Director, Urology Research Laboratory LABioMed-Harbor/UCLA, Professor, Endocrinology, Charles Drew University. Consecutive PhDs, Biochemistry, University of Buenos Aires and London. Professor of Biochemistry, Cell Biology, Central University of Venezuela, Visiting Professor/scholar, MIT, Caltech, City of Hope, UCLA. His current research interests focus on the modulation of stem cell differentiation by nitric oxide/cGMP, and myostatin, and its application to the therapy of erectile dysfunction, diabetic nephropathy, urogenital disease associated with tissue fibrosis. Funded by NIH, Department of Defense, and other agencies.
 
David A. Haake, MD
David A. Haake, MD
Dr. David Haake is a graduate of Harvard University and the New York University School of Medicine. He received his internal medicine and infectious diseases training at the UCLA Center for Health Sciences. He is currently a staff infectious diseases specialist at the Greater Los Angeles VA Healthcare System. His laboratory is developing electrochemical biosensors for rapid identification and antibiotic susceptibility testing of uropathogens. The "urosensor" assay can detect as few as 1 bacterium per sensor in less than 30 minutes. Rapid detection of drug-resistant bacterial pathogens would revolutionize treatment of urinary tract infections by enabling personalized antibiotic therapy.
 
Sally L. Maliski, PhD, RN, FAAN
Sally L. Maliski, PhD, RN, FAAN
Sally L. Maliski, PhD, RN, FAAN is an Associate Professor in Nursing and Urology and Associate Dean for Academic Affairs in the UCLA School of Nursing. Dr. Maliski received her PhD in Nursing from UNC-Chapel Hill after which she worked with Dr. Ruth McCorkle exploring nursing's impact on quality of life post-prostatectomy. From there, Dr. Maliski came to UCLA as a post-doctoral fellow quality of life with Dr. Linda Sarna and eventually working with Dr. Mark S. Litwin on multiple studies investigating quality of life and related issues among underserved men with prostate cancer and their partners.
 
Eric Vilain, MD, PhD
Eric Vilain, MD, PhD
Professor, Human Genetics, Pediatrics, Urology. His laboratory is funded by several National Institutes of Health grants and works at discovering the genetic bases of sex determination, sex differences in the brain and sexual orientation. He is an expert in the field of the genetics of sex differences, using both genetically engineered mouse models as well as patients with Disorders of Sex Development, and has deciphered a large number of molecular mechanisms responsible for intersexuality in humans. Dr. Vilain earned his B.S. in Biochemistry and Ph.D. in Genetics at Universite Pierre et Marie Curie, Paris; M.D., Faculte de Medicine Necker Enfants Malades.
 
Lily Wu, MD, PhD
Lily Wu, MD, PhD
Faculty member, Urology since 1998. Graduated, member of the inaugural class of Medical Scientist Training Program (M.D., Ph.D. program). Her education training ranges from clinical disciplines such as pediatrics and hematology/oncology to molecular and cellular fields such as adenovirus biology, transcription regulation, and gene therapy. Besides her research endeavors, a major part of her effort involves mentoring students at all levels, from undergraduates, graduate, postdoctoral fellows to clinical residents.
 
Gang Zeng, PhD
Gang Zeng, PhD
Associate Professor in Urologic Oncology and Member of the Jonsson Comprehensive Cancer Center. His current work is focused on cancer immunodiagnosis, immunotherapy, and prostate cancer stem cell biology.
 
UCLA Rated One of the Top Hospitals in the Nation